申请人:Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
公开号:EP3689860A1
公开(公告)日:2020-08-05
Provided is a sulfonyl-substituted bicyclic compound (A) which acts as a RORγ inhibitor, said compound has good RORγ inhibitory activity and is expected to be used for treating diseases mediated by a RORγ receptor in mammals.
本研究提供了一种磺酰基取代的双环化合物(A),它可作为 RORγ 抑制剂,所述化合物具有良好的 RORγ 抑制活性,有望用于治疗哺乳动物体内由 RORγ 受体介导的疾病。